About the Authors
- Che-Ming Liu
-
Contributed equally to this work with: Che-Ming Liu, Chia-Ling Hsieh
Affiliation Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan, ROC
- Chia-Ling Hsieh
-
Contributed equally to this work with: Che-Ming Liu, Chia-Ling Hsieh
Affiliations Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC, Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan, ROC
- Yun-Chi He
-
Affiliation Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC
- Sen-Jei Lo
-
Affiliation Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC
- Ji-An Liang
-
Affiliation Division of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan, ROC
- Teng-Fu Hsieh
-
Affiliations Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan, ROC, Division of Urology, Buddhist Tzu-Chi General Hospital, Taichung Branch, Taichung, Taiwan, ROC, Department of Urology, School of Medicine, Buddhist Tzu Chi University, Hualien, Taiwan, ROC
- Sajni Josson
-
Affiliation Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America
- Leland W. K. Chung
-
Affiliation Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, United States of America
- Mien-Chie Hung
-
Affiliations Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC, Department of Biotechnology, Asia University, Wufeng, Taichung, Taiwan, ROC, Department of Molecular and Cellular Oncology, M.D. Anderson Cancer Center, University of Texas, Houston, Texas, United States of America
- Shian-Ying Sung
-
* E-mail: ssung@mail.cmu.edu.tw
Affiliations Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan, ROC, Graduate Institutes of Cancer Biology, China Medical University, Taichung, Taiwan, ROC, Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan, ROC
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: SYS. Performed the experiments: CML YCH SJL TFH SJ SYS. Analyzed the data: CLH SYS MCH. Contributed reagents/materials/analysis tools: MCH JAL SYS LWKC. Wrote the paper: SYS.